65
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

, , , , , , , & show all
Pages 5711-5718 | Published online: 28 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dongbo Liu, Dingkun Wang, Cheng Wu, Linli Zhang, Qi Mei, Guangyuan Hu, Guoxian Long & Wei Sun. (2019) Prognostic significance of serum lactate dehydrogenase in patients with breast cancer: a meta-analysis. Cancer Management and Research 11, pages 3611-3619.
Read now
Minghong Li, Jian Wang & Haibo Liu. (2018) Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients. OncoTargets and Therapy 11, pages 6871-6877.
Read now
Chuansheng Li, Jingwei Zhang, Zhongliang Ma, Fan Zhang & Wenlong Yu. (2018) miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway. OncoTargets and Therapy 11, pages 4087-4095.
Read now

Articles from other publishers (11)

Elan C. McCarthy & Róisín M. Dwyer. (2021) Emerging Evidence of the Functional Impact of the miR379/miR656 Cluster (C14MC) in Breast Cancer. Biomedicines 9:7, pages 827.
Crossref
Hamid Najminejad, Behrouz Farhadihosseinabadi, Mehran Dabaghian, Asiyeh Dezhkam, Esmat Rigi Yousofabadi, Reza Najminejad, Meghdad Abdollahpour-Alitappeh, Mohammad Hossein Karimi, Nader Bagheri, Motahareh Mahi-Birjand, Nasrin Ghasemi, Mahta Mazaheri, Seyed Mehdi Kalantar, Alexander Seifalian & Mohammad Hasan Sheikhha. (2020) Key Regulatory miRNAs and their Interplay with Mechanosensing and Mechanotransduction Signaling Pathways in Breast Cancer Progression. Molecular Cancer Research 18:8, pages 1113-1128.
Crossref
Jingwei Zhang, Xia Kong, Qizhu Shi & Bin Zhao. (2020) MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer. Cancer Biomarkers 27:4, pages 423-432.
Crossref
Eleni Zografos, Flora Zagouri, Despoina Kalapanida, Roubini Zakopoulou, Anastasios Kyriazoglou, Kleoniki Apostolidou, Maria Gazouli & Meletios-Athanasios Dimopoulos. (2019) Prognostic role of microRNAs in breast cancer: A systematic review. Oncotarget 10:67, pages 7156-7178.
Crossref
Shangwen Liu, Yadong Wang, Wengang Li, Shaolong Yu, Zhipeng Wen, Zhifeng Chen & Feng Lin. (2019) miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. Biomedicine & Pharmacotherapy 119, pages 109406.
Crossref
Xiqi Peng, Xiang Pan, Kaihao Liu, Chunduo Zhang, Liwen Zhao, Hang Li, Xin Guan, Weijie Xu, Jinling Xu, Fangting Zhang & Yongqing Lai. (2019) miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery. The International Journal of Biological Markers 34:3, pages 302-308.
Crossref
Jie Li, Zhiyuan Zhang, Fangyu Chen, Tao Hu, Wen Peng, Qiou Gu & Yueming Sun. (2019) The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer. Frontiers in Oncology 9.
Crossref
Zhi‐Gao Hu, Chao‐Wen Zheng, Hui‐Zhao Su, Yong‐Lian Zeng, Cheng‐Jie Lin, Zhen‐Ya Guo, Fu‐Di Zhong, Guan‐Dou Yuan & Song‐Qing He. (2018) MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. Journal of Cellular Biochemistry 120:6, pages 9964-9978.
Crossref
Rama Rao Malla, Seema Kumari, Murali Mohan Gavara, Anil Kumar Badana, Shailender Gugalavath, Deepak Kakara Gift Kumar & Prasuja Rokkam. (2019) A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer. Biophysical Reviews 11:2, pages 227-234.
Crossref
Jintao Liu, Jinquan Liu & Xinyi Lu. (2018) HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer. Experimental and Therapeutic Medicine.
Crossref
Dongdong Wei, Yingbin Miao, Lianxia Yu, Degong Wang & Yingli Wang. (2018) Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN. Molecular Medicine Reports.
Crossref